 |
 |
| Nuclear receptor regulation of bile acid synthesis |
  |
|
John Y. L. Chiang, Ph.D.
(Northeastern Ohio University College of Medicine and Pharmacy, USA)
|
|
 |
| Mitochondrial cholesterol, a critical first hit in fatty liver disease |
|
|
|
Jose C. Fernandez-Checa, Ph.D.
(National Spanish Research Council, Spain)
|
|
 |
Molecular mechanisms underlying fat-
induced insulin resistance in the liver |
|
|
|
Toshinari Takamura, M.D., Ph.D.
(Kanazawa University Graduate School of Medical Science, Japan)
|
|
 |
| Role of ER Stress in Fatty Liver and Hepatic Injury |
|
|
|
Cheng Ji, Ph.D.
(University of Southern California, USA)
|
|
 |
Role of nuclear receptors in fatty liver
disease |
|
|
|
Yoong Joo Park, M.D., Ph.D.
(Seoul National University College of Medicine)
|
|
 |
| Orphan nuclear receptor and hepatic glucose metabolism |
|
|
|
Hueng-Sik Choi, Ph.D.
(Hormone Research Center, Chonnam National University)
|
|
 |
| Molecular targets for the treatment of hepatic steatosis in patients with insulin resistance |
|
|
|
Keun-Gyu Park, M.D., Ph.D.
(Keimyung University School of Medicine)
|
|
 |
| Bioengineering of Bioartificial Liver |
|
|
|
Jae-Sung Park, Ph.D.
(Postech)
|
|
 |
| Liver cirrhosis model |
|
|
|
박 억
(LG 생명과학)
|
|
 |
| Fatty liver model |
|
|
|
이경민, Ph.D.
(경북대학교)
|
|
|
|
